Position statement

Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An androgen excess society guideline

Ricardo Azziz, Enrico Carmina, Didier Dewailly, Evanthia Diamanti-Kandarakis, Hector F. Escobar-Morreale, Walter Futterweit, Onno E. Janssen, Richard S. Legro, Robert J. Norman, Ann E. Taylor, Selma F. Witchel

Research output: Contribution to journalReview article

992 Citations (Scopus)

Abstract

Objective: The Androgen Excess Society (AES) charged a task force to review all available data and recommend an evidence-based definition for polycystic ovary syndrome (PCOS), whether already in use or not, to guide clinical diagnosis and future research. Participants: Participants included expert investigators in the field. Evidence: Based on a systematic review of the published peer-reviewed medical literature, by querying MEDLINE databases, we tried to identify studies evaluating the epidemiology or phenotypic aspects of PCOS. Consensus Process: The task force drafted the initial report, following a consensus process via electronic communication, which was then reviewed and critiqued by the AES Board of Directors. No section was finalized until all members were satisfied with the contents and minority opinions noted. Statements that were not supported by peer-reviewed evidence were not included. Conclusions: Based on the available data, it is the view of the AES Task Force on the Phenotype of PCOS that there should be acceptance of the original 1990 National Institutes of Health criteria with some modifications, taking into consideration the concerns expressed in the proceedings of the 2003 Rotterdam conference. A principal conclusion was that PCOS should be first considered a disorder of androgen excess or hyperandrogenism, although a minority considered the possibility that there may be forms of PCOS without overt evidence of hyperandrogenism but recognized that more data are required before validating this supposition. Finally, the task force recognized, and fully expects, that the definition of this syndrome will evolve over time to incorporate new research findings.

Original languageEnglish (US)
Pages (from-to)4237-4245
Number of pages9
JournalJournal of Clinical Endocrinology and Metabolism
Volume91
Issue number11
DOIs
StatePublished - Jan 1 2006

Fingerprint

Polycystic Ovary Syndrome
Androgens
Advisory Committees
Guidelines
Hyperandrogenism
Consensus
Epidemiology
Peer Review
National Institutes of Health (U.S.)
MEDLINE
Health
Communication
Research Personnel
Databases
Phenotype
Research

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Position statement : Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An androgen excess society guideline. / Azziz, Ricardo; Carmina, Enrico; Dewailly, Didier; Diamanti-Kandarakis, Evanthia; Escobar-Morreale, Hector F.; Futterweit, Walter; Janssen, Onno E.; Legro, Richard S.; Norman, Robert J.; Taylor, Ann E.; Witchel, Selma F.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 91, No. 11, 01.01.2006, p. 4237-4245.

Research output: Contribution to journalReview article

Azziz, R, Carmina, E, Dewailly, D, Diamanti-Kandarakis, E, Escobar-Morreale, HF, Futterweit, W, Janssen, OE, Legro, RS, Norman, RJ, Taylor, AE & Witchel, SF 2006, 'Position statement: Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An androgen excess society guideline', Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 11, pp. 4237-4245. https://doi.org/10.1210/jc.2006-0178
Azziz, Ricardo ; Carmina, Enrico ; Dewailly, Didier ; Diamanti-Kandarakis, Evanthia ; Escobar-Morreale, Hector F. ; Futterweit, Walter ; Janssen, Onno E. ; Legro, Richard S. ; Norman, Robert J. ; Taylor, Ann E. ; Witchel, Selma F. / Position statement : Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An androgen excess society guideline. In: Journal of Clinical Endocrinology and Metabolism. 2006 ; Vol. 91, No. 11. pp. 4237-4245.
@article{5372ac04c2fd481aac6157746c70e835,
title = "Position statement: Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An androgen excess society guideline",
abstract = "Objective: The Androgen Excess Society (AES) charged a task force to review all available data and recommend an evidence-based definition for polycystic ovary syndrome (PCOS), whether already in use or not, to guide clinical diagnosis and future research. Participants: Participants included expert investigators in the field. Evidence: Based on a systematic review of the published peer-reviewed medical literature, by querying MEDLINE databases, we tried to identify studies evaluating the epidemiology or phenotypic aspects of PCOS. Consensus Process: The task force drafted the initial report, following a consensus process via electronic communication, which was then reviewed and critiqued by the AES Board of Directors. No section was finalized until all members were satisfied with the contents and minority opinions noted. Statements that were not supported by peer-reviewed evidence were not included. Conclusions: Based on the available data, it is the view of the AES Task Force on the Phenotype of PCOS that there should be acceptance of the original 1990 National Institutes of Health criteria with some modifications, taking into consideration the concerns expressed in the proceedings of the 2003 Rotterdam conference. A principal conclusion was that PCOS should be first considered a disorder of androgen excess or hyperandrogenism, although a minority considered the possibility that there may be forms of PCOS without overt evidence of hyperandrogenism but recognized that more data are required before validating this supposition. Finally, the task force recognized, and fully expects, that the definition of this syndrome will evolve over time to incorporate new research findings.",
author = "Ricardo Azziz and Enrico Carmina and Didier Dewailly and Evanthia Diamanti-Kandarakis and Escobar-Morreale, {Hector F.} and Walter Futterweit and Janssen, {Onno E.} and Legro, {Richard S.} and Norman, {Robert J.} and Taylor, {Ann E.} and Witchel, {Selma F.}",
year = "2006",
month = "1",
day = "1",
doi = "10.1210/jc.2006-0178",
language = "English (US)",
volume = "91",
pages = "4237--4245",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "11",

}

TY - JOUR

T1 - Position statement

T2 - Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An androgen excess society guideline

AU - Azziz, Ricardo

AU - Carmina, Enrico

AU - Dewailly, Didier

AU - Diamanti-Kandarakis, Evanthia

AU - Escobar-Morreale, Hector F.

AU - Futterweit, Walter

AU - Janssen, Onno E.

AU - Legro, Richard S.

AU - Norman, Robert J.

AU - Taylor, Ann E.

AU - Witchel, Selma F.

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Objective: The Androgen Excess Society (AES) charged a task force to review all available data and recommend an evidence-based definition for polycystic ovary syndrome (PCOS), whether already in use or not, to guide clinical diagnosis and future research. Participants: Participants included expert investigators in the field. Evidence: Based on a systematic review of the published peer-reviewed medical literature, by querying MEDLINE databases, we tried to identify studies evaluating the epidemiology or phenotypic aspects of PCOS. Consensus Process: The task force drafted the initial report, following a consensus process via electronic communication, which was then reviewed and critiqued by the AES Board of Directors. No section was finalized until all members were satisfied with the contents and minority opinions noted. Statements that were not supported by peer-reviewed evidence were not included. Conclusions: Based on the available data, it is the view of the AES Task Force on the Phenotype of PCOS that there should be acceptance of the original 1990 National Institutes of Health criteria with some modifications, taking into consideration the concerns expressed in the proceedings of the 2003 Rotterdam conference. A principal conclusion was that PCOS should be first considered a disorder of androgen excess or hyperandrogenism, although a minority considered the possibility that there may be forms of PCOS without overt evidence of hyperandrogenism but recognized that more data are required before validating this supposition. Finally, the task force recognized, and fully expects, that the definition of this syndrome will evolve over time to incorporate new research findings.

AB - Objective: The Androgen Excess Society (AES) charged a task force to review all available data and recommend an evidence-based definition for polycystic ovary syndrome (PCOS), whether already in use or not, to guide clinical diagnosis and future research. Participants: Participants included expert investigators in the field. Evidence: Based on a systematic review of the published peer-reviewed medical literature, by querying MEDLINE databases, we tried to identify studies evaluating the epidemiology or phenotypic aspects of PCOS. Consensus Process: The task force drafted the initial report, following a consensus process via electronic communication, which was then reviewed and critiqued by the AES Board of Directors. No section was finalized until all members were satisfied with the contents and minority opinions noted. Statements that were not supported by peer-reviewed evidence were not included. Conclusions: Based on the available data, it is the view of the AES Task Force on the Phenotype of PCOS that there should be acceptance of the original 1990 National Institutes of Health criteria with some modifications, taking into consideration the concerns expressed in the proceedings of the 2003 Rotterdam conference. A principal conclusion was that PCOS should be first considered a disorder of androgen excess or hyperandrogenism, although a minority considered the possibility that there may be forms of PCOS without overt evidence of hyperandrogenism but recognized that more data are required before validating this supposition. Finally, the task force recognized, and fully expects, that the definition of this syndrome will evolve over time to incorporate new research findings.

UR - http://www.scopus.com/inward/record.url?scp=33751526500&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751526500&partnerID=8YFLogxK

U2 - 10.1210/jc.2006-0178

DO - 10.1210/jc.2006-0178

M3 - Review article

VL - 91

SP - 4237

EP - 4245

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 11

ER -